FOR US HEALTH CARE PROFESSIONALS ONLY
Information on our pipeline products does not imply FDA approval for these products or uses, nor does it establish the safety or efficacy of these products or uses.
Select a section to view materials
Under investigation for the treatment of focal onset seizures, including resistant focal onset seizures.
FILTER
Filter by
Year
Poster content may not be subject to peer review and should be considered a preview of emerging data. Results may be subject to change upon final analysis. Posters may not be cited as reference sources. Poster data are time limited, and posters are subject to removal after publication or at the sponsor’s discretion.
Publications may contain data outside the approved product labeling. Supernus Pharmaceuticals does not support the use of its products in a manner that is not consistent with the product labeling.
